Emergent Biosolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate And Technology
Acquisition positions Emergent to offer the U.S. Government a domestic source for an advanced anthrax vaccine candidate to meet planned procurement of 25 million doses of rPA vaccine.
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed the acquisition of all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product [...]
Posted on July 11, 2009 at 4:00 pm by admin · Permalink
· Leave a comment
In: Uncategorized · Tagged with: Clinical trial, Fort Detrick, Strategic National Stockpile, United States, United States Department of Health and Human Services, US Food and Drug Administration, US government, VaxGen
In: Uncategorized · Tagged with: Clinical trial, Fort Detrick, Strategic National Stockpile, United States, United States Department of Health and Human Services, US Food and Drug Administration, US government, VaxGen